2NOJUS - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 292,399 | 313,886 | 170,595 | 141,362 | 152,759 | 186,956 | 156,680 | 202,670 |
| Profit before tax | - | - | - | - | - | -67,494 | -26,679 | -71,005 |
| Net profit | 10,002 | -9,807 | 19,562 | -26,860 | 13,251 | -67,494 | -26,679 | -71,005 |
| Equity | 2,896 | 8,800 | 28,363 | 1,503 | 14,754 | -51,773 | -78,452 | -149,457 |
| Liabilities | 152,282 | 120,212 | 98,764 | 86,098 | 138,480 | 192,632 | 188,412 | 179,830 |
| Non-current assets | 50,732 | 44,249 | 37,106 | 32,523 | 73,035 | 30,161 | 27,815 | 2,721 |
| Current assets | 120,156 | 84,763 | 90,021 | 55,078 | 80,199 | 110,698 | 81,952 | 27,482 |
| Total assets | 170,888 | 129,012 | 127,127 | 87,601 | 153,234 | 140,859 | 109,767 | 30,203 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 32,928 | 29,748 | 47,245 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +4.4% | +7.3% | -45.7% | -17.1% | +8.1% | +22.4% | -16.2% | +29.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 5.9% | -7.6% | 15.4% | -30.7% | 8.6% | -47.9% | -24.3% | -235.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 345.4% | -111.4% | 69.0% | -1787.1% | 89.8% | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 3.4% | -3.1% | 11.5% | -19.0% | 8.7% | -36.1% | -17.0% | -35.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | -36.1% | -17.0% | -35.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 52.6 | 13.7 | 3.5 | 57.3 | 9.4 | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 146,200 | 134,524 | 73,113 | 70,681 | 76,380 | 93,478 | 78,340 | 101,335 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
2NOJUS - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-03 | 2026-05-05 | 0.73 |
| 2026-04-20 | 2026-04-29 | 0.73 |
| 2026-03-29 | 2026-04-01 | 0.73 |
| 2026-03-17 | 2026-03-27 | 0.73 |
| 2026-02-18 | 2026-03-04 | 0.73 |
| 2026-01-22 | 2026-02-02 | 0.73 |
| 2025-10-16 | 2025-10-21 | 402.71 |
| 2024-11-18 | 2024-11-21 | 532.99 |
| 2024-07-24 | 2024-08-07 | 22.49 |
| 2024-07-16 | 2024-07-23 | 22.33 |
| 2024-06-18 | 2024-07-10 | 15.27 |
| 2024-05-16 | 2024-06-05 | 8.51 |
| 2024-04-23 | 2024-05-07 | 1.75 |
| 2024-04-16 | 2024-04-22 | 1.51 |
| 2024-03-18 | 2024-04-04 | 9.09 |
| 2024-01-15 | 2024-01-15 | 1.46 |
| 2023-12-18 | 2024-01-11 | 1.46 |
| 2023-11-16 | 2023-12-06 | 1.46 |
| 2023-10-25 | 2023-11-07 | 1.46 |
| 2023-08-17 | 2023-08-21 | 560.46 |
| 2023-07-28 | 2023-08-16 | 1.88 |
| 2023-07-24 | 2023-07-25 | 1.95 |
| 2023-06-16 | 2023-06-26 | 540.81 |
| 2021-12-16 | 2021-12-19 | 550.43 |
2NOJUS - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-11-30 | 2025-12-03 | 220.57 |
| 2025-11-12 | 2025-11-15 | 27206.94 |
| 2025-09-30 | 2025-11-11 | 27212.0 |
| 2025-09-28 | 2025-09-29 | 27219.08 |
| 2024-11-20 | 2024-11-23 | 82.24 |
| 2024-11-08 | 2024-11-19 | 81.81 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
2NOJUS, UAB is a Private Limited Liability Company (code 302705542) operating in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, the company generated revenue of €202.7K, up 29.4% year on year and 8.4% above the 2023 level. Despite the higher turnover, profitability remained negative, with a net loss of €71.0K and a profit margin of -35.0%. The loss widened compared with 2024, when revenue was €156.7K and the net loss was €26.7K, while 2023 ended with a loss of €67.5K on revenue of €187.0K. The balance sheet weakened further in 2025: total assets fell to €30.2K from €109.8K in 2024, while liabilities stood at €179.8K and equity remained deeply negative at -€149.5K. Asset turnover was 6.71x, and revenue per employee was €101.3K, indicating relatively strong sales generation per worker, although profit per employee was negative at -€35.5K.